Baidu
map

JCO:美国HIV感染人群患肛门癌的风险

2017-11-16 MedSci MedSci原创

HIV感染人群患肛门癌的风险增加。但是近些年的患病趋势及哪些人群能够从肿瘤监测中获益尚未得到完整的描述。JCO近期发表了一篇文章对这些问题进行研究。

HIV感染人群患肛门癌的风险增加。但是近些年的患病趋势及哪些人群能够从肿瘤监测中获益尚未得到完整的描述。JCO近期发表了一篇文章对这些问题进行研究。

作者研究了美国9个区域1996-2012年间HIV感染和肿瘤资料,比较HIV感染人群和正常人群标准化发病率,评估HIV感染不同亚群人群的肛门癌发病率及目前趋势。研究结果表明,在447953例HIV感染的人群中,肛门癌发病率显着高于正常人群。在男男性关系(MSM)人群肛门癌发病率最高,且随着年龄增加。AIDS病患者与无AIDS人群相比发病率更高。1996年到2000年间,HIV感染患者发病率快速增加,2001年到2008年达到平台期,2008年到2012年开始下降。HIV感染男男性关系人群年龄45-59岁及≥60岁时5年累计发病率高,AIDS男男性关系人群年龄30-44,45-59及≥60岁时5年累计发病率高。

文章最后认为,HIV感染人群肛门癌发病率显着增加,特别是在男男性关系、年龄较大及AIDS病人群中更为明显。近年来发病率下降反映了HIV治疗所发挥的作用。肛门癌累计发病率高的人群可以从肿瘤监测中获益。

原始出处:
Vivian Colon-Lopez,Meredith S.Shiels,et al.Anal Cancer Risk Among People With HIV Infection in the United States.JCO.November 15 2017 doi:10.1200/JCO.2017.74.9291

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=358564, encodeId=4ed735856434, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jan 18 21:08:37 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891457, encodeId=de69189145e18, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Sun Feb 25 17:22:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693714, encodeId=9b071693e149e, content=<a href='/topic/show?id=c8168114412' target=_blank style='color:#2F92EE;'>#肛门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81144, encryptionId=c8168114412, topicName=肛门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bc29444908, createdName=hxj0127, createdTime=Sat Jan 27 07:22:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261722, encodeId=c5b6261e222e, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Nov 16 12:51:25 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261703, encodeId=13b4261e0332, content=学习了很多先进的医疗技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Thu Nov 16 11:03:15 CST 2017, time=2017-11-16, status=1, ipAttribution=)]
    2019-01-18 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=358564, encodeId=4ed735856434, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jan 18 21:08:37 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891457, encodeId=de69189145e18, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Sun Feb 25 17:22:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693714, encodeId=9b071693e149e, content=<a href='/topic/show?id=c8168114412' target=_blank style='color:#2F92EE;'>#肛门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81144, encryptionId=c8168114412, topicName=肛门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bc29444908, createdName=hxj0127, createdTime=Sat Jan 27 07:22:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261722, encodeId=c5b6261e222e, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Nov 16 12:51:25 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261703, encodeId=13b4261e0332, content=学习了很多先进的医疗技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Thu Nov 16 11:03:15 CST 2017, time=2017-11-16, status=1, ipAttribution=)]
    2018-02-25 lidong40
  3. [GetPortalCommentsPageByObjectIdResponse(id=358564, encodeId=4ed735856434, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jan 18 21:08:37 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891457, encodeId=de69189145e18, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Sun Feb 25 17:22:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693714, encodeId=9b071693e149e, content=<a href='/topic/show?id=c8168114412' target=_blank style='color:#2F92EE;'>#肛门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81144, encryptionId=c8168114412, topicName=肛门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bc29444908, createdName=hxj0127, createdTime=Sat Jan 27 07:22:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261722, encodeId=c5b6261e222e, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Nov 16 12:51:25 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261703, encodeId=13b4261e0332, content=学习了很多先进的医疗技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Thu Nov 16 11:03:15 CST 2017, time=2017-11-16, status=1, ipAttribution=)]
    2018-01-27 hxj0127
  4. [GetPortalCommentsPageByObjectIdResponse(id=358564, encodeId=4ed735856434, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jan 18 21:08:37 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891457, encodeId=de69189145e18, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Sun Feb 25 17:22:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693714, encodeId=9b071693e149e, content=<a href='/topic/show?id=c8168114412' target=_blank style='color:#2F92EE;'>#肛门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81144, encryptionId=c8168114412, topicName=肛门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bc29444908, createdName=hxj0127, createdTime=Sat Jan 27 07:22:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261722, encodeId=c5b6261e222e, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Nov 16 12:51:25 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261703, encodeId=13b4261e0332, content=学习了很多先进的医疗技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Thu Nov 16 11:03:15 CST 2017, time=2017-11-16, status=1, ipAttribution=)]
    2017-11-16 中医痴

    不错的.学习了.谢谢分享.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=358564, encodeId=4ed735856434, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jan 18 21:08:37 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891457, encodeId=de69189145e18, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Sun Feb 25 17:22:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693714, encodeId=9b071693e149e, content=<a href='/topic/show?id=c8168114412' target=_blank style='color:#2F92EE;'>#肛门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81144, encryptionId=c8168114412, topicName=肛门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bc29444908, createdName=hxj0127, createdTime=Sat Jan 27 07:22:00 CST 2018, time=2018-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261722, encodeId=c5b6261e222e, content=不错的.学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Thu Nov 16 12:51:25 CST 2017, time=2017-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=261703, encodeId=13b4261e0332, content=学习了很多先进的医疗技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161027/IMG58114E1818EA51495.jpg, createdBy=4b2c1959822, createdName=雅文博武, createdTime=Thu Nov 16 11:03:15 CST 2017, time=2017-11-16, status=1, ipAttribution=)]
    2017-11-16 雅文博武

    学习了很多先进的医疗技术

    0

相关资讯

Obstet Gynecol:女性肛门癌与HPV感染间联系

英国妇女和婴儿医院的研究人员最近发表的一项研究结果显示,肛门癌与人乳头瘤病毒(HPV)感染有关。研究成果发表在Obstetrics & Gynecology。HPV与肛门癌相关,尤其是女性中。2014年,7200例肛门癌患者中有4500例为女性。因此女性既往HPV相关生殖器感染的既往史,将有助于肛门癌的筛查。通常对HIV阳性的男性和女性,以及男男性行为者进行肛门细胞学检查以筛查肛门癌。宫颈

2016IANS国际指南——肛门癌前兆检测实践标准发布

2016年8月,国际肛门肿瘤学会(IANS)发布了关于肛门癌前兆检测实践标准的国际指南,该指南建议了高分辨率肛门镜(HRA)临床检查的最低标准。全文获取:下载地址:指南下载 (需要扣积分2分, 梅斯医学APP免积分下载)

振奋人心!Advaxis公布ADXS-HPV治疗肛门癌早期研究数据

最近,著名的肿瘤免疫疗法公司Advaxis公布了利用公司开发的ADXS-HPV疗法结合放疗、化疗治疗肛门癌的临床一期研究数据。数据显示参与实验的25名患者都对这一联合疗法都表现出了完全反应,更令人瞩目的是所有患者至今都没有复发的迹象。Advaxis公司的此次研究是和美国布朗大学医学院联合进行的,旨在研究公司新开发的ADXS-HPV的有效性和安全性。作为肿瘤疾病中的罕见类型,肛门癌具有肿瘤复发率高的

Ann Oncol:肛门癌的欧洲新指南

针对肛门癌,欧洲的三个组织联合发表了新指南,对肛门癌的诊断、治疗和随访提供了新的指导意见。该指南发表在 7 月 6 日的 Annals of Oncology 在线期刊上。[pdf free] 这份新的指南代表了欧洲 3 个主要肿瘤治疗护理组织的联合意见,即 ESMO(European Society for Medical Oncology)、欧洲肿瘤外科协会(European Socie

JCO:西妥昔单抗联合放化疗治疗伴有HIV感染的肛门癌患者的效果有待商榷

肛管鳞状细胞癌(SCCAC)的产生与肛门生殖器人乳头状瘤病毒相关,并且患者常伴有HIV感染。同时,SCCAC在患者放化疗后常出现高局部缺血(LRF)率。由于西妥昔单抗可以增强人类乳头状瘤病毒引起的口咽SCC放化疗的治疗效果,因此试验旨在探索放化疗SCCAC中使用西妥昔单抗能否减小患者的LRF。

Conversation:感染艾滋病毒的同性恋和双性恋肛门癌流行及其预防方法

2014年,美国近620,000名同性恋双性恋男子感染艾滋病毒,其中10万人甚至不知道感染艾滋病毒。这些男性患肛门癌的可能性要比艾滋病毒阴性男性高出100倍。然而,在任何人群中,都没有针对肛门癌预防的国家筛查指南。

Baidu
map
Baidu
map
Baidu
map